BiotechTube
Home/DelSiTech/Martti Hedman
MH

Martti Hedman

Interim Chief Executive Officer

DelSiTech

Therapeutic Areas

Metabolic DiseasePain

DelSiTech Pipeline

DrugIndicationPhase
Lead long-acting injectable assetsMetabolic disease and painNot Specified

Leadership Team at DelSiTech

SH
Sari Häkkinen
Chief Development Officer
KR
Kristian Rantala
Chief Financial Officer
FD
Frederic Dargelas
Chief Commercial Officer
View full DelSiTech profile